Gilead Sciences (board member)
E84182
Gilead Sciences is a major American biopharmaceutical company known for developing antiviral drugs, including treatments for HIV, hepatitis C, and other serious diseases.
Aliases (1)
- Gilead Sciences ×52
Statements (49)
| Predicate | Object |
|---|---|
| instanceOf |
biopharmaceutical company
→
public company → |
| country |
United States
→
|
| developed |
bictegravir
→
emtricitabine → ledipasvir → remdesivir → sofosbuvir → tenofovir alafenamide → tenofovir disoproxil fumarate → velpatasvir → |
| focusesOn |
COVID-19 treatment
→
HIV treatment → antiviral drugs → hepatitis B treatment → hepatitis C treatment → |
| founded |
1987
→
|
| foundedBy |
John C. Martin
NERFINISHED
→
Michael L. Riordan → Other early co-founders and investors → Paris Panayiotopoulos → |
| foundedIn |
California
→
|
| hasBoardOfDirectors |
yes
→
|
| headquartersLocation |
Foster City, California, United States
→
|
| industry |
biotechnology
→
pharmaceuticals → |
| isMajorCompanyIn |
antiviral drug development
→
|
| knownFor |
HIV antiretroviral drugs
→
development of antiviral therapies → hepatitis C direct-acting antivirals → |
| listedOn |
NASDAQ
→
|
| operatesIn |
global market
→
|
| product |
Biktarvy
→
Descovy → Epclusa → Harvoni → Sovaldi → Truvada → Veklury → |
| researchFocus |
infectious diseases
→
inflammation → oncology → |
| revenueSource |
prescription drugs
→
|
| specializesIn |
COVID-19 therapeutics
→
HIV/AIDS therapeutics → inflammatory diseases → oncology → viral hepatitis therapeutics → |
| tickerSymbol |
GILD
→
|
Referenced by (4)
| Subject (surface form when different) | Predicate |
|---|---|
|
Donald Rumsfeld
("Gilead Sciences")
→
|
boardMemberOf |
|
oseltamivir
("Gilead Sciences")
→
|
developedBy |
|
Donald Rumsfeld
→
|
employer |
|
Granta Park
("Gilead Sciences")
→
|
hasTenant |